VMC Q1 2026 Earnings Strong EPS Beat Driven by Pricing and Cost Control Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development Inhibikase Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines OLLI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Retail Environment OPRX Q1 2026 Earnings Massive EPS Beat Driven by Strong Operational Performance ZOOZ Strategy Ltd ZOOZ Surges 858 as It Nears Key Resistance Level BRP Inc DOO Edges Higher to 5538 as Shares Test Key Levels Algorhythm Holdings RIME Slips 679 as Selling Pressure Tests Key Support Autozi Internet Technology AZI Edges Lower Amid Consolidation Key Levels in Focus VIVS Q3 2025 Earnings EPS Beat on Cost Management Amidst Ongoing Development